{"id":1631,"date":"2017-01-10T13:30:00","date_gmt":"2017-01-10T13:30:00","guid":{"rendered":"https:\/\/www.allenandallen.com\/breast-cancer-drug-taxotere-linked-to-permanent-hair-loss\/"},"modified":"2025-12-02T14:24:52","modified_gmt":"2025-12-02T19:24:52","slug":"farmaco-taxotere-para-el-cancer-de-mama-vinculado-a-la-perdida-permanente-del-cabello","status":"publish","type":"post","link":"https:\/\/www.allenandallen.com\/es\/blog\/breast-cancer-drug-taxotere-linked-to-permanent-hair-loss\/","title":{"rendered":"Taxotere, un f\u00e1rmaco contra el c\u00e1ncer de mama, vinculado a la p\u00e9rdida permanente del cabello"},"content":{"rendered":"

Taxotere, a chemotherapy drug manufactured by Sanofi-Aventis, has been linked to permanent hair loss in patients undergoing cancer treatment.[1]<\/a> While there are safe and effective alternative drugs that do not cause permanent hair loss, the side effect warnings for Taxotere indicate hair loss is only temporary. Of all patients with breast cancer who used Taxotere, approximately 9% suffer from permanent hair loss, according to doctors participating in Taxotere studies. This unintended effect irreversibly damages a woman\u2019s self-esteem, causes emotional distress, and can even lead to severe depression.<\/p>\n

Taxotere and hair loss (alopecia)<\/h2>\n

Taxotere (docetaxel) is a drug manufactured by Sanofi-Aventis to prevent cancer cells from growing and dividing. It is among the most popular chemotherapy drugs used to treat breast cancer, generating more than $3 billion in revenue prior to Sanofi-Aventis losing patent protection. The majority of women treated with Taxotere were unaware of the risk of alopecia due to Sanofi\u2019s negligence in warning the public. In fact, lawsuits are being filed across the nation, claiming that Sanofi hid research<\/strong> that links Taxotere to alopecia.<\/p>\n

What are the side effects of using Taxotere?<\/h2>\n

Numerous side effects are associated with Taxotere[2]<\/a> and include:<\/p>\n